DRREDDY

Dr. Reddy’s Laboratories Overview

Dr. Reddy’s Laboratories is a prominent Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana. Founded in 1984 by scientist and entrepreneur Dr. Kallam Anji Reddy, the company specializes in producing active pharmaceutical ingredients (APIs), generic medicines, biosimilars, and over-the-counter (OTC) healthcare products.📊 Corporate & Financial OverviewMarket Status: One of the top-ranked pharmaceutical companies in India, widely known for brands like the gastrointestinal medication ***** Exposure: Operates in over 80 countries, with significant market presence in the US, Europe, and emerging ***** Performance: Reported a consolidated annual revenue of ₹33,700.20 Crore for the financial year ending March ***** Market: Publicly traded on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) under the ticker DRREDDY. It also trades on the New York Stock Exchange (NYSE).💊 Core Business AreasGenerics & Biosimilars: Produces affordable versions of complex, off-patent medicines. Notably launched Obeda, India’s first DCGI-approved semaglutide injection/tablet generic for Type 2 ***** Focus: Key medical fields include gastroenterology, oncology, cardiovascular diseases, pain management, diabetes, and ***** Manufacturing: Manufactures and supplies raw active chemical ingredients to other pharma brands worldwide.